FDA PMA
FDA Class 3
Approved
🇺🇸 United States
System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
PMA: P230001
·
Supplement: S009
·
Decision Sep 15, 2025
Classifications
1
FEI Numbers
0
Registration Numbers
0
Basic Information
- Device Name
- System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection
- Trade Name
- ColoSense®
- PMA Number
- P230001
- Supplement Number
- S009
- Device Class
- FDA Class 3
- Product Code
- SBB
- Generic Name
- System, Colorectal Neoplasia, RNA Markers and Hemoglobin detection
- Medical Specialty
- Unknown
- Advisory Committee
- Pathology
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- September 15, 2025
- Date Received
- July 16, 2025
- Supplement Type
- Real-Time Process
- Supplement Reason
- Labeling Change - Indications/instructions/shelf life/tradename
- Expedited Review
- N
Advisory Committee Statement
Submission is approved.
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| SBB | System, Colorectal Neoplasia, Rna Markers And Hemoglobin Detection | FDA class 3 | Unknown |